- Home
- JKS vs VIR Comparison
JKS vs VIR Comparison
Compare JKS & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JKS
- VIR
- Stock Information
- Founded
- JKS 2006
- VIR 2016
- Country
- JKS China
- VIR United States
- Employees
- JKS N/A
- VIR N/A
- Industry
- JKS Semiconductors
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- JKS Technology
- VIR Health Care
- Exchange
- JKS Nasdaq
- VIR Nasdaq
- Market Cap
- JKS 1.4B
- VIR 1.4B
- IPO Year
- JKS 2010
- VIR 2019
- Fundamental
- Price
- JKS $21.24
- VIR $10.11
- Analyst Decision
- JKS Hold
- VIR Buy
- Analyst Count
- JKS 6
- VIR 6
- Target Price
- JKS $31.33
- VIR $34.83
- AVG Volume (30 Days)
- JKS 851.5K
- VIR 3.6M
- Earning Date
- JKS 10-30-2024
- VIR 02-20-2025
- Dividend Yield
- JKS 7.06%
- VIR N/A
- EPS Growth
- JKS N/A
- VIR N/A
- EPS
- JKS 0.89
- VIR N/A
- Revenue
- JKS $14,888,551,409.00
- VIR $78,618,000.00
- Revenue This Year
- JKS N/A
- VIR N/A
- Revenue Next Year
- JKS $5.44
- VIR N/A
- P/E Ratio
- JKS $23.99
- VIR N/A
- Revenue Growth
- JKS N/A
- VIR N/A
- 52 Week Low
- JKS $16.70
- VIR $6.56
- 52 Week High
- JKS $37.36
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- JKS 34.41
- VIR 59.21
- Support Level
- JKS $23.15
- VIR $9.92
- Resistance Level
- JKS $25.36
- VIR $11.24
- Average True Range (ATR)
- JKS 1.43
- VIR 0.86
- MACD
- JKS -0.50
- VIR 0.21
- Stochastic Oscillator
- JKS 3.30
- VIR 39.97
About JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific (except China, which includes Hong Kong and Taiwan), and the Rest of the world.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.